STOCK TITAN

Adagio Medical Holdings, Inc - ADGM STOCK NEWS

Welcome to our dedicated page for Adagio Medical Holdings news (Ticker: ADGM), a resource for investors and traders seeking the latest updates and insights on Adagio Medical Holdings stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Adagio Medical Holdings's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Adagio Medical Holdings's position in the market.

News
Rhea-AI Summary

Adagio Medical Holdings, Inc. (Nasdaq: ADGM), a leader in catheter ablation technologies for cardiac arrhythmias, has provided a business update highlighting significant milestones. The company has obtained CE Mark approval and initiated the commercial launch of its vCLAS™ catheter and ultra-low temperature cryoablation (ULTC) system for ventricular tachycardia (VT) treatment in Europe. Additionally, Adagio has received FDA approval for the FULCRUM-VT Pivotal IDE study in the US, with patient enrollment expected to begin in September.

The company recently closed a business combination with ARYA Sciences Acquisition Corp IV, resulting in its listing on the Nasdaq Capital Market under the ticker symbol 'ADGM'. This transaction, along with concurrent financings, raised approximately $84.2 million, leaving the company with a proforma cash-on-hand of about $35 million after closing.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none

FAQ

What is the current stock price of Adagio Medical Holdings (ADGM)?

The current stock price of Adagio Medical Holdings (ADGM) is $4.26 as of September 18, 2024.

What is the market cap of Adagio Medical Holdings (ADGM)?

The market cap of Adagio Medical Holdings (ADGM) is approximately 59.4M.

Adagio Medical Holdings, Inc

Nasdaq:ADGM

ADGM Rankings

ADGM Stock Data

59.44M
13.39M
0.33%
27.68%
0.66%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
LAGUNA HILLS